SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

The researchers took a “safety-first” approach. They deliberately excluded all viruses that infect humans or animals from the ...

Scientists have made the first step towards creating new species in the lab. Researchers have used artificial intelligence to ...

Mirum Pharmaceuticals acquires Bluejay Therapeutics, focusing on brelovitug for chronic hepatitis delta virus (HDV), a severe ...

Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV ...

The company’s sales grew 9.9% YoY – driven by a diverse range of portfolio classics and new launches.

Artistic initiatives turn cybersecurity into immersive exhibits at the Museum of Malware Art, transforming cyber threats into thought-provoking experiences ...

Zero trust offers organizations a way to help bolster security, but challenges remain when it comes to adoption and setting ...

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family Next-generation vaccine ...

Nipah is a rare viral infection that spreads largely from infected animals, mainly fruit bats, to humans. It can be asymptomatic but it is often very dangerous, with a case fatality rate of 40 to 75 ...

His containment strategy helped wipe out the disease in the 1970s, one of the world’s greatest public health triumphs. He ...